Assenagon Asset Management S.A. Homology Medicines, Inc. Transaction History

Assenagon Asset Management S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	BUY	$0.53 - $1.14 $6,876 - $14,791	12,975 Added 53.19%	37,367 $22,000
Q3 2023 Nov 06, 2023	SELL	$0.84 - $1.43 $21,104 - $35,927	-25,124 Reduced 50.74%	24,392 $28,000
Q2 2023 Jul 25, 2023	BUY	$0.83 - $1.12 $26,388 - $35,608	31,793 Added 179.39%	49,516 $43,000
Q1 2023 Apr 18, 2023	BUY	$0.91 - $1.69 $16,127 - $29,951	17,723 New	17,723 $18,000
Q2 2022 Jul 27, 2022	BUY	$1.39 - $3.12 $28,001 - $62,852	20,145 New	20,145 $40,000

Q3 2021 Oct 19, 2021	SELL	$6.01 - $8.71 $2.92 Million - $4.24 Million	-486,396 Closed	0 $0
Q2 2021 Jul 15, 2021	BUY	$6.02 - $9.64 $2.93 Million - $4.69 Million	486,396 New	486,396 $3.54 Million

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.